Acetylsalicylic acid Completed Phase 4 Trials for Novel P2Y12 Inhibitors / Platelet Function and Reactivity Tests / Acute Coronary Syndromes (ACS) Basic Science

Indications	Status	Purpose	Phase
DBCOND0068860 (Novel P2Y12 Inhibitors) DBCOND0068859 (Platelet Function and Reactivity Tests) DBCOND0034735 (Acute Coronary Syndromes (ACS))	Completed	Basic Science	4

clinicaltrials.gov Identifier	Title	Drugs
NCT02049762	Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy	Acetylsalicylic acid (DB00945)